The main determinants in CRP treatment are patient-related factors [26, 27], disease conditions including stage of cancer (all patients were with stage II and above) and presence of metastasis (42%), and healthcare provider-related factors [28] that may contribute to the undertreatment of cancer-related pain, which were not assessed in this study. Here, CRP is linked to cancer.